Lifeline Skin Care Grows Its Human Stem-Cell Anti-Aging Line
This article was originally published in The Rose Sheet
Lifeline Skin Care expands its offerings with an eye treatment featuring its patented stem-cell extract. Exec Linda Nelson explained International Stem Cell Corporation’s technology and its applications for Lifeline at the recent SupplySide West conference.
You may also be interested in...
“Healing peptide” from adult human stem cells, plant stem cells and an intercellular communication enhancer make up the proprietary StemCore-3 technology in Dermatech Research’s Stemology skin-care line. Products in the collection range from $189 for Cell Revive Serum Complete to $19 for cleansing items.
L’Oreal/Lancome’s claims for Genifique anti-aging products, among others, identify the products as drugs under food and drug law, according to FDA’s Sept. 7 warning letter. Agency cites claims suggesting the brand’s technology “boosts the activity of genes” and “improve[s] the condition around the stem cells” – language that is not altogether unique in today’s anti-aging cosmeceutical market.
Oceanside, Calif.-based International Stem Cell Corporation recently announced that Lifeline Skin Care, an anti-aging range based on the biotechnology firm's parthenogenetic stem-cell technology, is available to the public through the brand's website following a soft debut in November.